Figure 2 | Scientific Reports

Figure 2

From: Lipidomic-based investigation into the regulatory effect of Schisandrin B on palmitic acid level in non-alcoholic steatotic livers

Figure 2

Impacts of SchB treatments on lipidomic profiles in mouse models.

The Principle Component Analysis (PCA) of total lipids in (A) liver and (B) plasma samples in non-fasting mice, (C) liver and (D) plasma samples in fasting mice, (E) liver and (F) plasma samples in HFD-fed mice. nf-veh: non-fasting vehicle control group; nf-SchB: non-fasting SchB-treated group; f-veh: fasting vehicle control group; f-SchB: fasting SchB-treated group; control diet: control-diet-fed group; HFD: HFD-fed group; HFD-veh: HFD-fed vehicle control group; HFD-SchB: HFD-fed SchB-treated group.

Back to article page